London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here

Come to London


WATCH to find out why

Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Search Abstracts by author or title
(results will display both Free Papers & Poster)

Results of collagen cross-linking with riboflavin in paediatric patients with progressive keratoconus

Poster Details

First Author: B.Ratna INDIA

Co Author(s):    R. Bakshi              

Abstract Details


To assess the safety and efficacy of Corneal Collagen Cross linking with Riboflavin (CXL) using ultraviolet-A light in Children of 9-16 years of age with progressive keratoconus.


Centre For Sight


It was a retrospective case series of 25 eyes of 15 children with progressive keratoconus aged between 9-16 years. Mean follow up was 24.57 months (range 1 to 3 years). 6 out of 15 (40%) children had Vernal keratoconjunctivitis (VKC) associated keratoconus.


We had gratifying results in most of our patients. Mean pre-operative keratometry was 51.96 + 5.75 D, whereas which reduced to 48.73 + 3.83 D. Improvement in BCVA by one line or more was noted in all (100%) eyes at the last follow up. Mean pre-op aberration coefficient was 2.6+/-0.96 which reduced to 2.42+/-0.92 post operatively. There were no complications noted in our series except for mild haze and minimal scarring post-op which had no impact on BCVA


Our study concluded that Collagen Cross Linking with Riboflavin is a safe and effective procedure in children with progressive keratoconus. FINANCIAL INTEREST: NONE

Back to Poster listing